Compounds > niacinamide

niacinamide and 3-iodobenzylguanidine

niacinamide has been researched along with 3-iodobenzylguanidine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janssen, M; Loesberg, C; Smets, LA; Van Rooij, H1
Flad, HD; Hauschildt, S; Heine, H; Ulmer, AJ1
Flad, HD; Hauschildt, S; Heine, H; Heyden, T; Ulmer, AJ1
Andris, F; Daniel, J; Leo, O; Marechal, Y; Van Gool, F1

Other Studies

4 other study(ies) available for niacinamide and 3-iodobenzylguanidine

ArticleYear
Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis.
    Biochimica et biophysica acta, 1990, Aug-13, Volume: 1054, Issue:1

    Topics: 3-Iodobenzylguanidine; ADP Ribose Transferases; Animals; Benzamides; Cell-Free System; Cholera Toxin; Dexamethasone; Erythrocyte Membrane; Iodobenzenes; Leukemia L1210; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured

1990
Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Nov-15, Volume: 155, Issue:10

    Topics: 3-Iodobenzylguanidine; Cells, Cultured; Humans; Interleukin-6; Iodobenzenes; Lipopolysaccharides; Monocytes; Niacinamide; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Proteins; Tumor Necrosis Factor-alpha

1995
ADP-ribosylation: role in LPS-induced phosphorylation of two cytosolic proteins (p36/38) in monocytes.
    Progress in clinical and biological research, 1998, Volume: 397

    Topics: 3-Iodobenzylguanidine; Adenosine Diphosphate Ribose; Blood Proteins; Cytokines; Enzyme Inhibitors; Humans; Interleukin-1; Interleukin-6; Lipopolysaccharides; Monocytes; Niacinamide; Phosphorylation; RNA, Messenger; Tumor Necrosis Factor-alpha

1998
Nicotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction.
    Biochemical pharmacology, 2007, Mar-15, Volume: 73, Issue:6

    Topics: 3-Iodobenzylguanidine; Adenosine Diphosphate Ribose; Animals; Antibody Formation; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; B-Lymphocytes; Calcium; Female; Lectins, C-Type; Lymphocyte Activation; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Niacinamide; Receptors, Antigen, B-Cell

2007